SBIR-STTR Award

Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay
Award last edited on: 3/2/2021

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$595,243
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
David Camerini

Company Information

Antigen Discovery Inc (AKA: ImmPORT Therapeutics Inc)

One Technology Drive Suite E309
Irvine, CA 92618
   (949) 679-4068
   info@antigendiscovery.com
   www.antigendiscovery.com
Location: Single
Congr. District: 45
County: Orange

Phase I

Contract Number: 1R43AI136197-01
Start Date: 1/16/2018    Completed: 12/31/2019
Phase I year
2018
Phase I Amount
$299,564
Antibodies to many pathogenic viruses can be detected in blood, serum and/or saliva. Among these are many arboviruses, that share endemic regions in the western hemisphere and in other parts of the world. These include the related flaviviruses yellow fever virus (YFV), dengue virus (DENV), Zika virus (ZIKV) and West Nile virus (WNV) as well as the alphavirus chikungunya virus (CHIKV). Antibodies to these viruses are often cross-¬reactive, making diagnostics for a particular virus challenging. The current outbreak of yellow fever in Brazil and the high mortality associated with this disease as well as the recent history of outbreaks in South America and Africa create an urgent need for YFV--specific serodiagnostics, to aid control of the spread of yellow fever. Moreover, such diagnostics would facilitate clinical and public health efforts against these and other, related arboviruses. We propose a novel strategy to develop methods for specific and sensitive detection of antibodies against YFV that do not cross react with other arboviruses. We will employ an innovative, comprehensive proteomic approach with a unique serum sample collection that will allow discovery and validation of specific biomarkers capable of distinguishing YFV from other arboviruses. This will allow us to develop a specific and sensitive test for YFV infection in Phase II of this project. A practical, sensitive and specific test for YFV infection is a high priority goal due to the recent outbreak of yellow fever in Brazil, possible future outbreaks and the likely spread of yellow fever to southern US states bordering the Gulf of Mexico and Puerto Rico where Aedes spp. mosquitos might rapidly spread the infection.

Public Health Relevance Statement:
There is an urgent need for a specific diagnostic test for yellow fever virus, since yellow fever is often fatal and could spread to the USA from the recent outbreak in Brazil, as Zika virus did. Such a test is difficult to make due to cross-reactivity with other viruses. We propose a novel and comprehensive strategy to develop a specific test for yellow fever virus to help block the spread of yellow fever to the USA and Puerto Rico.

Project Terms:
Aedes; Algorithms; Alphavirus; Antibodies; Antigens; Arboviruses; Biological Assay; Brazil; Burkholderia pseudomallei; Chikungunya virus; Clinical; Colombia; Cross Reactions; cross reactivity; Culicidae; Dengue Infection; Dengue Virus; Detection; Development; Diagnostic; Diagnostic tests; Disease; Disease Outbreaks; Epidemic; Epitopes; Flavivirus; Future; Genome; Geographic state; Goals; Hawaii; Individual; Infection; innovation; Melioidosis; Methods; Mexico; mortality; novel; novel strategies; Pathogenicity; Patients; Pattern; Phase; point of care; Protein Fragment; Protein Microchips; Proteins; Proteome; Proteomics; Public Health; Puerto Rico; Recording of previous events; response; Saliva; sample collection; Sampling; Serum; South Africa; South America; specific biomarkers; Specificity; Technology; Testing; tool; Universities; Validation; Viral Proteins; Virus; Washington; West Nile viral infection; West Nile virus; Yellow Fever; Yellow fever virus; Yellow Fever Virus Infection; Zika Virus

Phase II

Contract Number: 5R43AI136197-02
Start Date: 1/16/2018    Completed: 12/31/2020
Phase II year
2019
Phase II Amount
$295,679
Over the last several years, DARPA has made a huge investment in developing fiber-based high energy lasers (HELs). These efforts include Endurance, Excalibur and more recently FLASH. The FLASH program is focused on installing a HEL in the pod of a fig Discovery of Yellow Fever Virus-­Specific Epitopes for Development of an Accurate Serodiagnostic Assay. Abstract: Antibodies to many pathogenic viruses can be detected in blood, serum and/or saliva. Among these are many arboviruses, that share endemic regions in the western hemisphere and in other parts of the world. These include the related flaviviruses yellow fever virus (YFV), dengue virus (DENV), Zika virus (ZIKV) and West Nile virus (WNV) as well as the alphavirus chikungunya virus (CHIKV). Antibodies to these viruses are often cross-­reactive, making diagnostics for a particular virus challenging. The current outbreak of yellow fever in Brazil and the high mortality associated with this disease as well as the recent history of outbreaks in South America and Africa create an urgent need for YFV-­specific serodiagnostics, to aid control of the spread of yellow fever. Moreover, such diagnostics would facilitate clinical and public health efforts against these and other, related arboviruses. We propose a novel strategy to develop methods for specific and sensitive detection of antibodies against YFV that do not cross react with other arboviruses. We will employ an innovative, comprehensive proteomic approach with a unique serum sample collection that will allow discovery and validation of specific biomarkers capable of distinguishing YFV from other arboviruses. This will allow us to develop a specific and sensitive test for YFV infection in Phase II of this project. A practical, sensitive and specific test for YFV infection is a high priority goal due to the recent outbreak of yellow fever in Brazil, possible future outbreaks and the likely spread of yellow fever to southern US states bordering the Gulf of Mexico and Puerto Rico where Aedes spp. mosquitos might rapidly spread the infection.

Public Health Relevance Statement:
Discovery of Yellow Fever Virus-­Specific Epitopes for Development of an Accurate Serodiagnostic Assay. Abstract : There is an urgent need for a specific diagnostic test for yellow fever virus, since yellow fever is often fatal and could spread to the USA from the recent outbreak in Brazil, as Zika virus did. Such a test is difficult to make due to cross-­reactivity with other viruses. We propose a novel and comprehensive strategy to develop a specific test for yellow fever virus to help block the spread of yellow fever to the USA and Puerto Rico.

NIH Spending Category:
Biodefense; Biotechnology; Emerging Infectious Diseases; Infectious Diseases; Rare Diseases; Vector-Borne Diseases; West Nile Virus.

Project Terms:
Aedes; Algorithms; Alphavirus; Antibodies; Antigens; Arboviruses; Biological Assay; Brazil; Burkholderia pseudomallei; Chikungunya virus; Clinical; Colombia; Cross Reactions; cross reactivity; Culicidae; Dengue Infection; Dengue Virus; Detection; Development; Diagnostic; Diagnostic tests; Disease; Disease Outbreaks; Epidemic; Epitopes; Flavivirus; Future; Genome; Geographic state; Goals; Hawaii; Individual; Infection; innovation; Melioidosis; Methods; Mexico; mortality; novel; novel strategies; pathogenic virus; Patients; Pattern; Phase; point of care; Protein Fragment; Protein Microchips; Proteins; Proteome; Proteomics; Public Health; Puerto Rico; Recording of previous events; response; Saliva; sample collection; Sampling; Serum; South Africa; South America; specific biomarkers; Specificity; Technology; Testing; tool; Universities; Validation; Viral Proteins; Virus; Washington; West Nile viral infection; West Nile virus; Yellow Fever; Yellow fever virus; Yellow Fever Virus Infection; Zika Virus hte...